| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-07-28 | NCT07732075 Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06439563 | Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced… | Peptic Ulcer | Recruiting |
| NCT07160790 | Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive… | Non-erosive Gastroesophageal Reflux Disease | Not Yet Recruiting |
| NCT07732075 | Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in… | Maintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD) | Not Yet Recruiting |
| Phase 2 | |||
| NCT05475184 | A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant… | Ovarian Cancer | Active, Not Recruiting |
| NCT07370818 | To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as… | Ovarian Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05257993 | Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified… | Pancreatic Ductal Adenocarcinoma | Recruiting |
| NCT07364422 | To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy… | Gastric Cancer (GC) | Not Yet Recruiting |
| Phase 1 | |||
| NCT07265466 | to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between… | Drug Drug Interaction (DDI) | Recruiting |
| NCT07570186 | Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male… | Healthy Volunteers | Not Yet Recruiting |